Multiple immune signaling proteins

The term 'Multiple immune signaling proteins' is a collective designation for a diverse array of molecules that mediate communication and regulation within the immune system. This group includes cytokines (e.g., interleukins, interferons), chemokines, cell surface receptors, and intracellular signaling transducers like Janus kinases (JAKs) and STAT proteins (NIH, 2020). These proteins play critical roles in orchestrating inflammatory responses, pathogen defense, and tissue repair, but their dysregulation is a hallmark of autoimmune diseases, chronic inflammation, and cancer (PubMed, 2026). Because this term refers to a broad category rather than a single molecular entity, it is not considered a specific therapeutic target in drug development. Instead, drugs are designed to target individual components within this group, such as TNF-alpha inhibitors or JAK inhibitors, to achieve precise therapeutic effects (ResearchGate, 2025). In clinical research, proteomic profiling of these proteins is often used to assess systemic changes in the tumor microenvironment or response to surgery (NIH, 2020; PubMed, 2026). Consequently, this entry is classified as 'incorrect' for structured target identification due to its lack of molecular specificity.

Other names

Immune signaling moleculesInflammatory mediatorsCytokines and chemokinesImmune-related proteins

Varies by specific protein; includes cytokine neutralization, receptor antagonism, and kinase inhibition.